Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor
摘要
The present invention relates to a unitary dosage form comprising: (a) a solid amorphous dispersion comprising a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer; and (b) an HMG-CoA reductase inhibitor; wherein said concentration-enhancing polymer is a neutralized acidic polymer in which at least 90% of the acidic moieties have been neutralized.